Articles On Paragon Care (ASX:PGC)

ASX healthcare sector gains 1.99% in November while benchmark ASX 200 down 2.66% Mach7 rises 50% in November with health imaging stock outlining a growth strategy at its AGM  Island Pharmaceuticals rises after FDA confirms Galidesivir will...

ASX healthcare sector fell 4.83% in October and is down more than 19% YTD CSL shares fall more than 15% on October 28 after management trims FY26 guidance Nyrada surges 165% in October on board changes and progress in phase 2a trial    Wi...

The S&P ASX 200 Health Care index fell 13.21% in August as a tough reporting season weighed on sector CSL had its biggest ever one day fall on August 19, down 17% following softer FY25 results and restructure plans Despite the broader...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin FNArena's Monitor keeps track of corporate earnings result releases, including broke...

The S&P ASX 200 Health Care index rose 9.05% in July with rotation into the sector gaining momentum  Lumos soared 170% in July after six-year exclusive deal valued at up to US$317 million with PHASE Scientific for distribution of Febri...

The ASX 200 Health Care Index fell 1.05% in June and remains the worst performing sector YTD down 6.64% Morgans healthcare analyst Iain Wilkie said June likely saw some tax loss selling before EOFY  Amplia up 300% in June after complete re...

The S&P/ASX 200 Health Care Index rose 1.59% in May but remains worst performing sector YTD down 5.65% Morgans healthcare analyst Iain Wilkie said US President Donald Trump’s trade and health policies continue to impact sector Lumos up...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin ASX futures are set to rise at the open after US markets ended flat (S&P500) to...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin US equities markets fell on rising bond yields, including a weak US 20-year bond auc...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin US markets eased overnight after a six-day winning streak as investors rotated into...

Highlights: ASX 200 lifted following RBA’s cash rate cut, led by real estate and tech stocks Financials and consumer discretionary sectors recorded upward momentum Resources and energy shares, especially gold, trailed amid g...

The S&P/ASX 200 Health Care Index rose 2.16% in April with the S&P/ASX 200 rallying 3.6% Morgans healthcare analyst Iain Wilkie said April was a marked improvement on recent months Several approvals during April, including for EBR...

I like finding ASX small-cap stocks with an exciting future that the market could be undervaluing. In this article, I'll discuss the ASX healthcare share Paragon Care Ltd (ASX: PGC). Paragon describes itself as a leading provider of medi...

The S&P/ASX 200 Health Care Index fell 7.66% in February with the S&P/ASX 200 down 3.79% Morgans healthcare analyst Iain Wilkie said several factors caused investor jitters in February including job cuts to US FDA  Pacific Edge was...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Welcome to the FNArena Corporate Results Monitor. Today’s Reports: ((ACF)) – Acrow...

The S&P/ASX 200 Health Care Index fell 1.85% in December but rose 7.51% overall in 2024  Mesoblast surged 52% in December after the US FDA approved its cell therapy Ryoncil for treatment of paediatric GvHD Percheron plunged 91% in Dece...

The ASX small-cap share space could be a great place to find under-researched but highly potential businesses. The fewer professional analysts looking at a stock, the higher the chance of that business slipping under the market's radar a...

The S&P/ASX 200 Health Care Index rose 2.89% in November as momentum returned to the sector Health cryogenic services company Vitrafy and nerve-repair biotech Renerve debuted on the ASX  Paradigm Biopharmaceuticals rose 151% in Novembe...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Traders and investors have been reminded about Trump’s social media posts as a sourc...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Donald Trump’s pick of hedge fund manager Scott Bessent for Treasury secretary and a...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin The FNArena database tabulates the views of eight major Australian and international...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin SPI futures are indicating a positive start to the new week for the local bourse. On...

The Vanguard Australian Shares Index ETF (ASX: VAS) is trading for $104.59 per unit, up 1.15% at the time of writing on Friday. This popular ASX exchange-traded fund (ETF) seeks to track the S&P/ASX 300 Index (ASX: XKO) before fees....

ASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results Artrya and Nyrada make key clinical advances   The S&P/ASX 200 Health Care [XHJ] index was down 0.9% gain in October. For the year, th...

Highlights Amotiv positioned as a resilient player in the automotive sector Temple & Webster shows strong growth in the homewares segment Paragon Care gaining market share in healthcare services Amotiv, formerly known as GUD...

Control Bionics says it has overcome the “challenges” of the 2023-24 year Ord Minnett identifies the health sector stunners Noxopharm finds a drug manufacturer to kick-start its lupus trial   Health Check is renowned biotech journo Tim Bo...

Healthcare stocks are doing relatively well globally in 2024
 The sector could see more recovery as Fed cuts rates
 How ASX biotechs performed in the month of September   The S&P 500 Health Care Index, a key world benchmark for health...

ASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing; sector outpaced benchmark 10x since 2006 AI is revolutionising healthcare, boosting diagnosis and treatment   The ASX Healthcare Index (AS...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((4DX)) - 4DMed...

S&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expected Fed rate cuts; ResMed seen as a strong buy And ASX healthcare winners and losers in July   The S&P/ASX 200 Health Care index [XHJ]...

The EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-listed company that collaborates with Eisai We take a look at the best performing ASX health stocks in the past month   In a major blow for...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin New research on the Pharmaceutical Wholesaling sector identifies three stocks with l...

The ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biotechs in June were Actinogen, Optiscan and EZZ Life Science, amongst others    The S&P/ASX 200 Health Care index [XHJ] saw a 4% increase...

 S&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biotech stocks We take a look at the ASX biotech winners for the month   The  S&P/ASX 200 Health Care [XHJ] closed flattish for the month o...

Research shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase the risk of dementia We look at the best performing ASX stocks over the past month    The phrase ‘you are what you eat’ was coined almost a c...

Momentum trading involves taking advantage of, and making profits from, upward trends in a stock. The strategy makes a calculated bet that the stock market’s recent winners will remain winners. The Relative Strength Index (RSI) is a popular...

ASX Health sector was in correction territory in April Why is the health sector different from other sectors? We look at the best performing ASX health stocks for the month   The S&P/ASX 200 Health Care [XHJ] had a soft month in April...

There’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to control sebum production We look at the best and worst performing ASX health stocks in the past month   Scientists have made a significant b...

The DroneShield Ltd (ASX: DRO) share price is on the move again on Thursday. In morning trade, the counter drone technology company's shares were up as much as 9% to 75.5 cents. However, its shares have since pulled back and are now tradin...

It has been another busy week for Australia's top brokers. This has led to the release of a number of broker notes. Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX sh...

ASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essentially, biotech is a long term game for investors   The S&P/ASX 200 Health Care [XHJ] struggled in February, finishing -1.5% lower and tr...

The S&P/ASX 200 Index (ASX: XJO) is having a poor session on Wednesday. In afternoon trade, the benchmark index is down 0.25% to 7,705.2 points. Four ASX shares that are not letting that hold them back are listed below. Here's why th...

Have you been keeping an eye on the resurgent ASX gold rush? Or perhaps you've already joined in. If you did catch the fast-spreading gold fever and bought S&P/ASX 200 Index (ASX: XJO) gold shares five days ago, you should be sitting...

It was another bumpy but unsuccessful day for the S&P/ASX 200 Index (ASX: XJO) and most ASX shares this Tuesday. Today's trading saw the ASX 200 swing between...

The ASX 200 traded sideways on Tuesday, closing the day flattish as gains in healthcare stocks were offset by losses in other sectors. Source: Market Index  Healthcare gained after the Albanese government approved an increase in private hea...

Medical equipment maker ParagonCare (ASX: PGC) has announced a “transformative” merger with CH2 Holdings to create a premier healthcare wholesaler, distributor and manufacturer operating across growing markets in the Asia Pacific region. Th...

Motley Fool Australia Chief Investment Officer Scott Phillips joined Natalia Cooper for Nine's Late News on Monday night to discuss falling building approvals and the challenges facing the economy as businesses destock, putting pressure on...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is edging higher. At the time of writing, the benchmark index is up slightly to 7,740.6 points. Four ASX shares that are rising more than most today are listed below. Here's why they...

Well, earnings season is over for another six months. And there was a lot to take in. (Quick plug: Members of Motley Fool services can expect some additional video content on earnings season over the next few weeks, so stay tuned!) But one...